Martyna Choinka

Martyna Choinka

Auto-generated profile, based on publicly available information

Martyna Choinka

University Clinical Hospital in Poznan, Przybyszewskiego Str. 49, 60-355 Poznan, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
AKAgata Konopka
Agata Konopka
ZSZuzanna Szczepaniak
Zuzanna Szczepaniak
NWNatalia Wdowiak
Natalia Wdowiak
KLKARINA KLAUDIA LISSAK
KARINA KLAUDIA LISSAK
MKMałgorzata Komarów
Małgorzata Komarów
JKJakub Kalisiak
Jakub Kalisiak
Introduction: TORCH syndrome refers to a group of symptoms caused by congenital infections with teratogenic pathogens, including Toxoplasma gondii, Varicella, Treponema pallidum, Parvovirus B19, Rubella, Cytomegalovirus (CMV), and Herpes simplex virus (HSV). It can also encompass infections like HIV, Zika virus (ZIKV), hepatitis B, and SARS-CoV-2. These pathogens can pass through the placenta, overcoming various placental barriers. Infections during pregnancy can result in severe consequences for both the fetus and the mother. Common symptoms in newborns include low birth weight, rashes, hepatosplenomegaly, cardiac anomalies, jaundice, chorioretinitis, and microcephaly, with 2% to 3% of congenital anomalies attributed to perinatal infections. The incidence of these infections varies globally. Purpose of the work: This study aims to review and characterize TORCH syndrome and the prevention of TORCH infections. Materials and methods: A comprehensive analysis of research papers available on PubMed, Google Scholar, Web of Science, Embase and Scopus was undertaken using the searchterms encompassing the following keywords: TORCH syndrome / infections during pregnancy / perinatal infections / Toxoplasmosis / Rubella / CMV infection / Herpes Simplex Virus infection / Parvovirus B19 / Treponema pallidum / vaccinations before and during pregnancy / maternal nutrition. Results: TORCH syndrome is a significant issue causing congenital diseases, premature births, and intrauterine deaths, impacting babies throughout their lives. Most complications can be prevented with proper prophylaxis and early treatment. Increasing awareness and providing education for women from preconception through the early postnatal period is essential. Addressing TORCH syndrome remains a major medical challenge, but improving management offers hope for better outcomes.

25 October 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
NWNatalia Wdowiak
Natalia Wdowiak
MCMartyna Choinka
Martyna Choinka
AKAgata Konopka
Agata Konopka
ZSZuzanna Szczepaniak
Zuzanna Szczepaniak
KAKinga Adamska
Kinga Adamska
Introduction: Wilson's disease (WD) is a genetic disease, inherited in an autosomal recessive manner, caused by a mutation in the ATP7B gene, which results in impaired excretion of copper in the bile. This causes the accumulation of copper in various tissues and organs, leading to their damage. The range and severity of symptoms are wide, so diagnosis is difficult and requires a high index of suspicion. The most common clinical symptoms are hepatic and neuropsychiatric symptoms. Diagnosis is based primarily on clinical suspicion, typical symptoms and reduced serum ceruloplasmin concentration. Treatment includes pharmacological therapies, and in some cases liver transplantation is necessary. Wilson's disease, if left untreated, inevitably leads to serious disability and death. Purpose of the work: This study aims to review and characterize the clinical and pathophysiological aspects of Wilson’s disease. Materials and methods: A comprehensive analysis of research papers available on PubMed, Google Scholar, Web of Science, Embase and Scopus was undertaken using the searchterms encompassing the following keywords: Wilson’s disease, Copper metabolism, Copper toxicity, ATP7B, Ceruloplasmin, Gene Mutation Results: Wilson's disease is a rare genetic disorder that can lead to severe disability and even death. For this reason, rapid diagnosis and appropriately selected and individualized treatment play a key role. Wilson's disease remains a major diagnostic challenge, but new techniques for its diagnosis, such as genotype analysis, mainly through sequencing, as well as newborn screening, may significantly improve patient prognosis in the future.

16 September 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
ZSZuzanna Szczepaniak
Zuzanna Szczepaniak
AKAgata Konopka
Agata Konopka
NWNatalia Wdowiak
Natalia Wdowiak
KLKARINA KLAUDIA LISSAK
KARINA KLAUDIA LISSAK
MKMałgorzata Komarów
Małgorzata Komarów
JKJakub Kalisiak
Jakub Kalisiak
Introduction: Congenital adrenal hyperplasia (CAH) is a group of diseases in which genetic defects occur that disturb the synthesis of cortisol. The most common variant of CAH (95%-99%) is caused by 21-hydroxylase deficiency as a result of mutations in the CYP21A2 gene and is one of the most common monogenic diseases. CAH is characterized by androgen overproduction along with variable degrees of cortisol and aldosterone deficiency. Age at diagnosis can provide some information about the underlying mutations, with those diagnosed at birth/early infancy being at greater risk of developing serious enzyme defects. Classic and non-classical forms of this disorder have been described in the literature. CAH diagnosis is based on the clinical presentation, hormonal panel, Adrenocorticotropic Hormone (ACTH) stimulation test, and genetic testing. The main goals of treatment for congenital adrenal hyperplasia are glucocorticoid/mineralcorticoid supplementation, control of high adrenal androgen levels, fertility control, genetic counseling, and optimization of patients’ quality of life. Purpose of the work: This study aims to review and characterize the clinical and pathophysiological aspects of congenital adrenal hyperplasia. Materials and methods: A comprehensive analysis of research papers available on PubMed, Google Scholar, Web of Science, Embase and Scopus was undertaken using the searchterms encompassing the following keywords: congenital adrenal hyperplasia, 21-hydroxylase deficiency, CYP21A2 Results: Congenital adrenal hyperplasia is a heterogeneous group of genetic disorders that can lead to serious and even fatal complications in the form of adrenal crisis. Therefore, screening tests and early diagnosis are crucial and can save the lives of newborns. Treatment should be individualized and allow patients to achieve normal growth, sexual development, fertility and a better quality of life.

29 September 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
KLKARINA KLAUDIA LISSAK
KARINA KLAUDIA LISSAK
ZSZuzanna Szczepaniak
Zuzanna Szczepaniak
AKAgata Konopka
Agata Konopka
NWNatalia Wdowiak
Natalia Wdowiak
MCMartyna Choinka
Martyna Choinka
BOBartłomiej Orzeł
Bartłomiej Orzeł
Uveal melanoma (UM) is a serious condition requiring immediate medical attention. It is the most common primary intraocular cancer in adults, with an incidence of around 5.2 cases per million people annually. Nearly half of UM patients develop metastatic disease, most often affecting the liver. UM refers to any malignant tumor arising from melanocytes in the uveal tract, which includes the iris, ciliary body, and choroid. Treatment options for UM depend on several factors, including tumor size, location, and the patient's overall health. These options may include radiation therapy, surgery, laser treatments, targeted therapies, and immunotherapy. UM is often described as an immune-privileged tumor, with a distinct immune profile compared to cutaneous melanoma (CM). This article aims to highlight the unique characteristics and challenges associated with this rare form of melanoma. By providing detailed information, the article seeks to enhance understanding and management of this rare form of melanoma.

24 September 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
ASAnna Szpernalowska
Anna Szpernalowska
VMVimbisoyashe Ivy Matshaba
Vimbisoyashe Ivy Matshaba
KMKarolina Mrugała
Karolina Mrugała
MCMartyna Choinka
Martyna Choinka
JKJakub Kalisiak
Jakub Kalisiak
MPMichał Paprocki
Michał Paprocki
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition marked by deficits in social communication and the presence of restricted, repetitive behaviours. Despite the global prevalence of ASD, its diagnosis and treatment remain challenging due to the absence of specific biomarkers and the heterogeneity of symptoms. ASD is incurable and current management options aim to minimize the symptoms and maximize the patients’ ability to function. There is no one standardized treatment for ASD at present, recommended medical interventions involve various therapies which include cognitive behavioral therapy alongside additional personalized pharmacological symptomatic treatments. New approach for ASD management includes sensory integration therapy (SIT) as well as dietary interventions, like gluten-free, casein-free and ketogenic diets. Other innovative treatment strategies are targeted at gut microbiome and include probiotic treatment and fecal microbiota transplant. In this review possible genetic variants associated with ASD are discussed as well as their influence on the manifestation and management of clinical symptoms. For a better understanding on how genetic variables impact drug effectiveness in individuals and the importance of pharmacogenetics in ASD. This paper aims to explore the available and possible treatment options as well the genetic components associated with ASD. In summary, this paper reviews the current and emerging treatment options for ASD.

11 September 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MCMartyna Choinka
Martyna Choinka
MKMałgorzata Komarów
Małgorzata Komarów
NWNatalia Wdowiak
Natalia Wdowiak
KLKARINA KLAUDIA LISSAK
KARINA KLAUDIA LISSAK
ZSZuzanna Szczepaniak
Zuzanna Szczepaniak
DKDominika Karasińska
Dominika Karasińska
Atopic dermatitis is a long-term inflammatory skin disease caused by factors such as skin barrier dysfunction and immune system dysregulation . Currently, the first-line treatment for atopic dermatitis involves the use of topical glucocorticosteroids; however, this treatment is associated with many side effects. Therefore the need of finding new methods of treatment arises. Objective: The objective of this study is to gather and analyze literature on new methods of treating atopic dermatitis. Materials and methods: The review was based on the analysis of materials collected in the database, PubMed, Google Scholar, Web of Science, Embaseand, Scopus, books and other scientific articles.